A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA) — Stella

Home/Takayasu's Arteritis/

View on ClinicalTrials.gov

Recruiting

Back to Takayasu's Arteritis trials

Trial locations(1 site)

China

Beijing Anzhen Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Collaborators

Shanghai Zhongshan Hospital, Peking University People's Hospital

Enrollment target

~1,000 participants

Started

January 2016

Primary completion

December 2026

Age range

18 Years – 70 Years

Last updated April 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.